Milestone Scientific (MLSS) – Press Releases
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
-
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
-
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
-
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
-
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast
-
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update
-
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
-
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
-
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock
-
Milestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures
-
Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain
-
Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023
-
Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York
-
Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors
-
Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023
-
Milestone Scientific Schedules Second Quarter 2023 Financial Results and Business Update Conference Call
-
Milestone Scientific Announces Positive Insurance Payment for the CompuFlo® Epidural System
-
Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California
-
Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023
-
Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in Oregon
-
Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
-
Milestone Scientific Provides 2022 Year-End Business Update
-
Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the University Pain and Spine Center which Operates 7 Locations Across New Jersey and New York
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Three Prominent Colorado Pain Management Clinics
-
Milestone Scientific Granted U.S. Government’s System for Award Management (SAM) Registration of its CompuFlo® Epidural System
-
Milestone Scientific Announces 510(k) FDA Clearance for the Use of CompuFlo Epidural System in Thoracic Indications
-
Milestone Scientific Announces Distribution Agreement with Leading European Dental Distributor & Manufacturer Sweden & Martina
-
Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil
-
Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman as Chairman of the Board of Directors
-
Milestone Scientific Achieves Revenue of $2.2 Million for the Third Quarter of 2022
-
Milestone Scientific Schedules Third Quarter 2022 Financial Results and Business Update Conference Call
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL Health
-
Milestone Scientific Provides Business Update for the Second Quarter of 2022
-
Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call
-
Milestone Scientific Announces Distribution Agreement with Clinical Technology, Inc. for the CompuFlo® Epidural System
-
Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum
-
Milestone Scientific Names Hager & Werken as Exclusive STA Single Tooth Anesthesia System® Distributor in Germany and Austria
-
Milestone Scientific Inc. Announces F&M Feed as an Exclusive Distributor in Greece and Commences Sales of CompuFlo® Epidural Instrument
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables to a Leading Medical Center in Southern California
-
American Medical Association Issues Technology-Specific CPT® Code for Milestone Scientific’s CompuFlo Epidural System
-
Milestone Scientific Expands Medical Indications for the CompuFlo® Epidural Instrument and Commences Disposable Sales to a Leading Veterinary and Academic Institution
-
Milestone Scientific Announces the Appointment of Retail Industry Veteran Ms. Benedetta Casamento to its Board of Directors
-
Milestone Scientific Achieves Revenue of $2.7 Million and Provides Business Update for the First Quarter of 2022
-
Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call
-
Milestone Scientific to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st
Back to MLSS Stock Lookup
